We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Living on the edge: inhibition of host cell apoptosis by Mycobacterium tuberculosis

    Volker Briken

    † Author for correspondence

    Department of Cell Biology & Molecular Genetics and, The Marlyand Pathogen Research Institute, University of Maryland, Microbiology Bldg 231, Room 2201, College Park, MD 20742, USA.

    &
    Jessica L Miller

    Department of Cell Biology & Molecular Genetics and, The Marlyand Pathogen Research Institute, University of Maryland, College Park, MD 20742, USA

    Published Online:https://doi.org/10.2217/17460913.3.4.415

    Tuberculosis is a human disease of global importance caused by infection with Mycobacterium tuberculosis. Thus, an estimated one-third of the world’s population is latently infected; there are 2–3 million annual deaths and an increasing amount of multidrug-resistant and extensive drug-resistant tuberculosis cases. M. tuberculosis is a highly adapted human pathogen that has evolved to employ multiple strategies in its attempt to avoid an efficient host immune response. The induction of host cell death is an ancient immune defense strategy that is conserved throughout the animal and plant kingdoms. Here we review the current status of the research involving interaction of mycobacteria with host cells, regarding the induction of host cell death by apoptosis. We conclude that virulent strains of M. tuberculosis employ several strategies to avoid the induction of macrophage cell death, and success in this process is clearly important for bacterial virulence. The molecular mechanisms of host cell apoptosis inhibition are little understood, but the recent identification of anti-apoptosis genes in the genome of M. tuberculosis has provided the tools necessary to investigate the details of this host–pathogen interaction. The results of these future studies may prove useful for the development of new drug targets and/or vaccine candidates.

    Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.

    Bibliography

    • Schnappinger D, Schoolnik GK, Ehrt S: Expression profiling of host pathogen interactions: how Mycobacterium tuberculosis and the macrophage adapt to one another. Microbes Infect.8,1132–1140 (2006).
    • Deretic V, Singh S, Master S et al.: Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell. Microbiol.8,719–727 (2006).
    • Houben EN, Nguyen L, Pieters J: Interaction of pathogenic mycobacteria with the host immune system. Curr. Opin. Microbiol.9,76–85 (2006).
    • Russell DG: Who puts the tubercle in tuberculosis? Nat. Rev. Microbiol.5,39–47 (2007).
    • Abramovitch RB, Martin GB: Strategies used by bacterial pathogens to suppress plant defenses. Curr. Opin. Plant Biol.7,356–364 (2004).
    • Iriti M, Faoro F: Review of innate and specific immunity in plants and animals. Mycopathologia164,57–64 (2007).
    • Carmen JC, Sinai AP: Suicide prevention: disruption of apoptotic pathways by protozoan parasites. Mol. Microbiol.64,904–916 (2007).
    • Boya P, Pauleau AL, Poncet D, Gonzalez-Polo RA, Zamzami N, Kroemer G: Viral proteins targeting mitochondria: controlling cell death. Biochim. Biophys. Acta1659,178–189 (2004).
    • Hilleman MR: Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc. Natl Acad. Sci. USA101(Suppl. 2),14560–14566 (2004).
    • 10  Keckler MS: Dodging the CTL response: viral evasion of Fas and granzyme induced apoptosis. Front. Biosci.12,725–732 (2007).
    • 11  Klingler K, Tchou-Wong KM, Brandli O et al.: Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes. Infect. Immun.65,5272–5278 (1997).
    • 12  Placido R, Mancino G, Amendola A et al.: Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. J. Pathol.181,31–38 (1997).
    • 13  Keane J, Balcewicz-Sablinska MK, Remold HG et al.: Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun.65,298–304 (1997).
    • 14  Danelishvili L, McGarvey J, Li YJ, Bermudez LE: Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell. Microbiol.5,649–660 (2003).
    • 15  Ciaramella A, Cavone A, Santucci MB et al.: Induction of apoptosis and release of interleukin-1-β by cell wall-associated 19-kDa lipoprotein during the course of mycobacterial infection. J. Infect. Dis.190,1167–1176 (2004).
    • 16  Arcila ML, Sanchez MD, Ortiz B, Barrera LF, Garcia LF, Rojas M: Activation of apoptosis, but not necrosis, during Mycobacterium tuberculosis infection correlated with decreased bacterial growth: role of TNF-α, IL-10, caspases and phospholipase A2. Cell. Immunol.249,80–93 (2007).
    • 17  Rojas M, Barrera LF, Puzo G, Garcia LF: Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. J. Immunol.159,1352–1361 (1997).•• Together with [23], this study proposes that the capacity of the host cell macrophage to undergo apoptosis but not necrosis is a factor in determining the susceptibility of a mouse strain to mycobacterial infections.
    • 18  Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG: Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α. J. Immunol.161,2636–2641 (1998).
    • 19  Velmurugan K, Chen B, Miller JL et al.: Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLOS Pathogens3,e110 (2007).•• Demonstrates via ‘gain-of-function’ and ‘loss-of-function’ genetic approaches that virulent Mycobacterium tuberculosis inhibits apoptosis, and that this is important for bacterial virulence.
    • 20  Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A, Nutman TB: Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood102,672–681 (2003).
    • 21  Lee J, Remold HG, Ieong MH, Kornfeld H: Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J. Immunol.176,4267–4274 (2006).• New caspase-independent cell death pathway may promote bacterial escape and extracellular replication.
    • 22  O’Sullivan MP, O’Leary S, Kelly DM, Keane J: A caspase-independent pathway mediates macrophage cell death in response to Mycobacterium tuberculosis infection. Infect. Immun.75,1984–1993 (2007).• New caspase-independent cell death pathway may promote bacterial escape and extracellular replication.
    • 23  Pan H, Yan BS, Rojas M et al.: Ipr1 gene mediates innate immunity to tuberculosis. Nature434,767–772 (2005).•• Together with [17], proposes that the capacity of the host cell macrophage to undergo apoptosis but not necrosis is a factor in determining the susceptibility of a mouse strain to mycobacterial infections.
    • 24  Keane J, Remold HG, Kornfeld H: Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol.164,2016–2020 (2000).•• Reports that only virulent mycobacterial species are able to inhibit apoptosis induction in primary human alveolar macrophages, and thus provides correlative evidence that host cell apoptosis inhibition is a virulence mechanism of M. tuberculosis.
    • 25  Riendeau CJ, Kornfeld H: THP-1 cell apoptosis in response to mycobacterial infection. Infect. Immun.71,254–259 (2003).• Demonstrates that the human acute monocytic leukemia cell line reflects the interaction of primary human alveolar macrophages with M. tuberculosis with regard to apoptosis induction, and is therefore a useful model cell line.
    • 26  Dhiman R, Raje M, Majumdar S: Differential expression of NF-κB in mycobacteria infected THP-1 affects apoptosis. Biochim. Biophys. Acta1770,649–658 (2007).
    • 27  Zhang J, Jiang R, Takayama H, Tanaka Y: Survival of virulent Mycobacterium tuberculosis involves preventing apoptosis induced by Bcl-2 upregulation and release resulting from necrosis in J774 macrophages. Microbiol. Immunol.49,845–852 (2005).
    • 28  Hinchey J, Lee S, Jeon BY et al.: Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J. Clin. Invest.117,2279–2288 (2007).•• First demonstration that a pro-apoptotic mutant of M. tuberculosis induces increased cross-presentation and cross-priming of CD8 T cells.
    • 29  Jayakumar D, Jacobs WR Jr, Narayanan S: Protein kinase E of Mycobacterium tuberculosis has a role in the nitric oxide stress response and apoptosis in a human macrophage model of infection. Cell. Microbiol.10(2),365–374 (2007).
    • 30  Braunstein M, Espinosa BJ, Chan J, Belisle JT, Jacobs WR Jr: SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol. Microbiol.48,453–464 (2003).
    • 31  Oddo M, Renno T, Attinger A, Bakker T, MacDonald HR, Meylan PR: Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol.160,5448–5454 (1998).• Establishes that M. tuberculosis inhibits Fas ligand (FasL)-mediated apoptosis.
    • 32  Fan T, Lu H, Hu H et al.: Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med.187,487–496 (1998).
    • 33  Chen M, Gan H, Remold HG: A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J. Immunol.176,3707–3716 (2006).
    • 34  Miyairi I, Byrne GI: Chlamydia and programmed cell death. Curr. Opin. Microbiol.9,102–108 (2006).
    • 35  Losick VP, Isberg RR: NF-κB translocation prevents host cell death after low-dose challenge by Legionella pneumophila. J. Exp. Med.203,2177–2189 (2006).
    • 36  Santic M, Asare R, Doric M, Abu Kwaik Y: Host-dependent trigger of caspases and apoptosis by Legionella pneumophila. Infect. Immun.75,2903–2913 (2007).
    • 37  Dobos KM, Spotts EA, Quinn FD, King CH: Necrosis of lung epithelial cells during infection with Mycobacterium tuberculosis is preceded by cell permeation. Infect. Immun.68,6300–6310 (2000).
    • 38  Hsu T, Hingley-Wilson SM, Chen B et al.: The primary mechanism of attenuation of bacillus Calmette-Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc. Natl Acad. Sci. USA100,12420–12425 (2003).
    • 39  Maiuri MC, Zalckvar E, Kimchi A, Kroemer G: Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell. Biol.8,741–752 (2007).
    • 40  Siegel RM: Caspases at the crossroads of immune-cell life and death. Nat. Rev. Immunol.6,308–317 (2006).
    • 41  Sly LM, Hingley-Wilson SM, Reiner NE, McMaster WR: Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J. Immunol.170,430–437 (2003).
    • 42  Kremer L, Estaquier J, Brandt E, Ameisen JC, Locht C: Mycobacterium bovis bacillus Calmette-Guérin infection prevents apoptosis of resting human monocytes. Eur. J. Immunol.27,2450–2456 (1997).
    • 43  Kausalya S, Somogyi R, Orlofsky A, Prystowsky MB: Requirement of A1-A for bacillus Calmette-Guérin-mediated protection of macrophages against nitric oxide-induced apoptosis. J. Immunol.166,4721–4727 (2001).
    • 44  Rohan D, Mahesh K, Manoj R, Sekhar M: Inhibition of bfl-1/A1 by siRNA inhibits mycobacterial growth in THP-1 cells by enhancing phagosomal acidification. Biochim. Biophys. Acta (2008) (Epub ahead of print).
    • 45  Spira A, Carroll JD, Liu G et al.: Apoptosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: a pivotal role for tumor necrosis factor. Am. J. Respir. Cell. Mol. Biol.29,545–551 (2003).
    • 46  Maiti D, Bhattacharyya A, Basu J: Lipoarabinomannan from Mycobacterium tuberculosis promotes macrophage survival by phosphorylating Bad through a phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem.276,329–333 (2001).
    • 47  Loeuillet C, Martinon F, Perez C, Munoz M, Thome M, Meylan PR: Mycobacterium tuberculosis subverts innate immunity to evade specific effectors. J. Immunol.177,6245–6255 (2006).• Establishes that M. tuberculosis inhibits FasL-mediated apoptosis.
    • 48  Fratazzi C, Arbeit RD, Carini C et al.: Macrophage apoptosis in mycobacterial infections. J. Leukoc. Biol.66,763–764 (1999).
    • 49  Molloy A, Laochumroonvorapong P, Kaplan G: Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J. Exp. Med.180,1499–1509 (1994).
    • 50  Fratazzi C, Arbeit RD, Carini C, Remold HG: Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol.158,4320–4327 (1997).
    • 51  Keane J, Shurtleff B, Kornfeld H: TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-γ independent manner. Tuberculosis (Edinb.)82,55–61 (2002).
    • 52  Schaible UE, Winau F, Sieling PA et al.: Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat. Med.9,1039–1046 (2003).•• Together with [54], demonstrates that the ‘detour’ pathways of cross-presentation leads to increased CD8 T-cell priming against mycobacterial antigens.
    • 53  Guermonprez P, Amigorena S: Pathways for antigen cross presentation. Springer Semin. Immunopathol.26,257–271 (2005).
    • 54  Winau F, Weber S, Sad S et al.: Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity24,105–117 (2006).•• Together with [52], demonstrates that the detour pathways of cross-presentation leads to increased CD8 T-cell priming against mycobacterial antigens.
    • 55  Edwards KM, Cynamon MH, Voladri RK et al.: Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med.164,2213–2219 (2001).
    • 56  Briken V, Porcelli SA, Besra GS, Kremer L: Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol.53,391–403 (2004).
    • 57  Karakousis PC, Bishai WR, Dorman SE: Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell. Microbiol.6,105–116 (2004).
    • 58  Briken V: Molecular mechanisms of host–pathogen interactions and their potential for the discovery of new drug targets. Curr. Drug Targets9,150–157 (2008).
    • 59  Grode L, Seiler P, Baumann S et al.: Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. J. Clin. Invest.115,2472–2479 (2005).•• First demonstration that the vaccine capacity of Mycobacterium bovis Bacille Calmette-Guérin can be improved by increasing its pro-apoptotic potential.